Organogenesis Holdings Inc. Files 2024 10-K
Ticker: ORGO · Form: 10-K · Filed: Feb 27, 2025 · CIK: 1661181
| Field | Detail |
|---|---|
| Company | Organogenesis Holdings INC. (ORGO) |
| Form Type | 10-K |
| Filed Date | Feb 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, financials
TL;DR
Organogenesis dropped its 2024 10-K. Full year financials are in.
AI Summary
Organogenesis Holdings Inc. filed its 2024 10-K on February 27, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly Avista Healthcare Public Acquisition Corp., is based in Canton, MA, and operates in the pharmaceutical preparations sector. Key financial details and operational aspects for the fiscal year 2024 are presented in this annual report.
Why It Matters
This filing provides a comprehensive overview of Organogenesis's financial health and business operations for the past fiscal year, crucial for investors and stakeholders to assess performance and future outlook.
Risk Assessment
Risk Level: medium — This is a standard annual financial filing providing historical data and forward-looking statements, typical for publicly traded companies.
Key Numbers
- 1231 — Fiscal Year End (Indicates the end of the reporting period for financial statements.)
- 001-37906 — SEC File Number (Unique identifier for the company's filings with the SEC.)
- 000000000 — IRS Number (Company's Internal Revenue Service identification number.)
Key Players & Entities
- Organogenesis Holdings Inc. (company) — Filer of the 10-K
- Avista Healthcare Public Acquisition Corp. (company) — Former name of Organogenesis Holdings Inc.
- 2024-12-31 (date) — Fiscal year end date
- 2025-02-27 (date) — Filing date of the 10-K
- Canton, MA (location) — Company's business and mailing address
FAQ
What is the primary business of Organogenesis Holdings Inc. as indicated in the filing?
Organogenesis Holdings Inc. operates in the Pharmaceutical Preparations sector, SIC code 2834.
When did Organogenesis Holdings Inc. change its name from Avista Healthcare Public Acquisition Corp.?
The company changed its name on December 15, 2015.
What is the filing date of this 10-K report?
This 10-K report was filed on February 27, 2025.
What is the fiscal year end date for Organogenesis Holdings Inc. in this report?
The fiscal year end date for this report is December 31, 2024.
Where is Organogenesis Holdings Inc. located?
The company's business and mailing address is 85 Dan Road, Canton, MA 02021.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 27, 2025 regarding Organogenesis Holdings Inc. (ORGO).